Quantitative FDG PET/CT in the community: Experience from interpretation of outside oncologic PET/CT exams in referred cancer patients

Journal of Medical Imaging and Radiation Oncology

Volumn 58, Issue 2, 2014, Pages 183-188

  Tahari, Abdel K ^a   Wahl, Richard L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

FDG; PET CT; quantitative PET; standardisation; SUV

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; BODY HEIGHT; BODY WEIGHT; CANCER PATIENT; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH INSURANCE; HUMAN; INFORMED CONSENT; LEAN BODY WEIGHT; LIVER; MAJOR CLINICAL STUDY; MALE; PATIENT REFERRAL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; WHOLE BODY CT; WHOLE BODY PET; COMPUTER ASSISTED TOMOGRAPHY; MIDDLE AGED; MULTIMODAL IMAGING; NEOPLASMS; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TERTIARY CARE CENTER;

FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; MULTIMODAL IMAGING; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REFERRAL AND CONSULTATION; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TERTIARY CARE CENTERS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84897580465     PISSN: 17549477     EISSN: 17549485     Source Type: Journal    
DOI: 10.1111/1754-9485.12140     Document Type: Article

References (15)

1. Weber WA,. Use of PET for monitoring cancer therapy and for predicting outcome. J Nucl Med 2005; 46: 983-995. PubMed PMID: 15937310. Epub 2005/06/07. eng.
2. Wahl RL, Zasadny K, Helvie M, Hutchins GD, Weber B, Cody R,. Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation. J Clin Oncol 1993; 11: 2101-2111. PubMed PMID: 8229124. Epub 1993/11/01. eng.
3. Sugawara Y, Zasadny KR, Neuhoff AW, Wahl RL,. Reevaluation of the standardized uptake value for FDG: variations with body weight and methods for correction. Radiology 1999; 213: 521-525. PubMed PMID: 10551235. Epub 1999/11/07. eng.
4. Nakamoto Y, Zasadny KR, Minn H, Wahl RL,. Reproducibility of common semi-quantitative parameters for evaluating lung cancer glucose metabolism with positron emission tomography using 2-deoxy-2-[18F]fluoro-D-glucose. Mol Imaging Biol 2002; 4: 171-178. PubMed PMID: 14537140. Epub 2003/10/11. eng.
5. Young H, Baum R, Cremerius U, Herholz K, Hoekstra O, Lammertsma AA, et al. Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET study group. Eur J Cancer 1999; 35: 1773-1782. PubMed PMID: 10673991. Epub 2000/02/16. eng.
6. Shankar LK, Hoffman JM, Bacharach S, Graham MM, Karp J, Lammertsma AA, et al. Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials. J Nucl Med 2006; 47: 1059-1066. PubMed PMID: 16741317. Epub 2006/06/03. eng.
7. Fletcher JW, Djulbegovic B, Soares HP, Siegel BA, Lowe VJ, Lyman GH, et al. Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med 2008; 49: 480-508. PubMed PMID: 18287273. Epub 2008/02/22. eng.
8. Wahl RL, Jacene H, Kasamon Y, Lodge MA,. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med 2009; 50 (Suppl 1): 122S-150. PubMed PMID: 19403881. Pubmed Central PMCID: 2755245. Epub 2009/06/24. eng.
9. Graham MM, Badawi RD, Wahl RL,. Variations in PET/CT methodology for oncologic imaging at U.S. academic medical centers: an imaging response assessment team survey. J Nucl Med 2011; 52: 311-317. PubMed PMID: 21233185. Epub 2011/01/15. eng.
10. Paquet N, Albert A, Foidart J, Hustinx R,. Within-patient variability of 18F-FDG: standardized uptake values in normal tissues. J Nucl Med 2004; 45: 784-788.
11. Laffon E, Adhoute X, de Clermont H, Marthan R, Is Liver SUV,. Stable over time in 18F-FDG PET imaging? J Nucl Med Technol 2011; 39: 258-263.
12. McCollough CH, Primak AN, Braun N, Kofler J, Yu L, Christner J,. Strategies for reducing radiation dose in CT. Radiol Clin North Am 2009; 47: 27-40. PubMed PMID: 19195532. Pubmed Central PMCID: 2743386. Epub 2009/02/07. eng.
13. Singh S, Kalra MK, Thrall JH, Mahesh M,. CT radiation dose reduction by modifying primary factors. J Am Coll Radiol 2011; 8: 369-372. PubMed PMID: 21531317. Epub 2011/05/03. eng.
14. McCollough CH, Bruesewitz MR, Kofler JM Jr,. CT dose reduction and dose management tools: overview of available options. Radiographics 2006; 26: 503-512. PubMed PMID: 16549613. Epub 2006/03/22. eng.
15. Kalra MK, Maher MM, Toth TL, Schmidt B, Westerman BL, Morgan HT, et al. Techniques and applications of automatic tube current modulation for CT. Radiology 2004; 233: 649-657. PubMed PMID: 15498896. Epub 2004/10/23. eng.